Last reviewed 11 May 2022

From 14 October 2022, companies will be expected to comply with new changes to REACH information requirements.

ECHA explains the changes include the following.

  • Requirements and specific rules for adaptation of:

    • in vitro and in vivo mutagenicity studies, specifying when further studies are needed based on mutagenicity concerns

    • reproductive toxicity studies, specifying the preferred animal species and administration routes, and clarifying the conditions triggering the need for further studies based on concerns

    • aquatic toxicity studies, clarifying when long-term studies must be performed instead of short-term studies or in addition to them

    • toxicity studies on terrestrial and sediment organisms, specifying when long-term studies are needed instead of short-term studies and clarifying that long-term testing must investigate both degradation and transformation products

    • degradation and bioaccumulation studies, specifying when further testing is needed, including investigation of both degradation and transformation products.

  • The obligation for only representatives to provide details on the non-EU manufacturer they represent.

  • Substance identification information including:

    • the requirement to describe the compositions, nanoform or set of similar nanoforms related to information submitted to fulfil information requirements under Annex VII-X of REACH

    • new requirements for reporting a crystal structure and for reporting compositions for substances with unknown or variable composition, complex reaction products or of biological materials (UVCBs)

    • clarified requirements for reporting constituents, impurities, and additives as well as for analytical information.

More information can be found on ECHA’s website.